Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

ANAGRELIDE MEVON CAPSULES 0.5 MG

Approval Number

SIN17118P

Drug Name

ANAGRELIDE MEVON CAPSULES 0.5 MG

Product Name

ANAGRELIDE MEVON CAPSULES 0.5 MG

Approval Date

October 17, 2024

Registrant

NOVEM PHARMA PRIVATE LIMITED

Regulatory Information

Registrant

NOVEM PHARMA PRIVATE LIMITED

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE

Route of Administration

ORAL

Medical Information

ATC Code

L01XX35

Manufacturer Information

Pharmaceutical Manufacturer

NOVEM PHARMA PRIVATE LIMITED

Manufacturers

Titan Laboratories Pvt. Ltd.

Active Ingredients

Ingredient Name

Anagrelide HCl eqv Anagrelide

Strength

0.5 mg

Drug MonographAnagrelide

Documents

Package Inserts

Anagrelide Mevon Capsule PI.pdf

Approved: October 17, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

ANAGRELIDE MEVON CAPSULES 0.5 MG - HSA Approval | MedPath